Vaccine

• Dr. Casey Means' nomination for U.S. surgeon general is stalled after senators from both parties questioned her vaccine views and limited medical experience during a confirmation hearing last month. • The 38-year-old Stanford-educated physician, who left her surgical residency, faces scrutiny for her alignment with Health Secretary Robert F. Kennedy Jr.'s vaccine rollback efforts. • Despite White House and activist support, Means needs full Republican backing on the Senate HELP Committee, but two GOP senators remain opposed amid legal setbacks for Kennedy's agenda.

Judge voids Kennedy’s ACIP picks, leaving key flu, Covid and RSV vaccine recommendations in limboSign up for the Breaking News US email to get newsletter alerts in your inboxAmid upheaval to the US vaccine advisory committee Robert Malone, the former co-chair and controversial figure who has opposed vaccines, says he has been pushed out and won’t be involved in any future decisions. The move comes after a federal judge stayed the appointment of 13 members of the advisory committee on immunization practices (ACIP), essentially invalidating their roles on the committee and the decisions they have made.Those new advisers were all hand-picked by Department of Health and Human Services (HHS) secretary, Robert F Kennedy Jr, after he fired the previous 17 members of ACIP in June – but the judge ruled they were unqualified and not selected properly. Continue reading...

• A federal judge blocked sweeping changes to U.S. vaccine recommendations, including reductions in childhood immunizations and removal of COVID-19 guidance for certain groups, in a lawsuit brought by the American Academy of Pediatrics and other medical groups. • The ruling paused a reconstituted vaccine advisory committee and signals a forthcoming decision on broader legal questions, with the case expected to reach the U.S. Supreme Court soon. • Changes were driven by RFK's authority over federal vaccine policy, which critics argue lack scientific basis and threaten public health.

• The FDA approved the first RSV vaccine for infants via maternal immunization on March 18, 2026, allowing pregnant women to receive vaccination in the third trimester to confer passive immunity to newborns. • The approval is based on a Phase 3 trial showing 82% efficacy in preventing severe RSV disease in infants under six months, with passive immunity lasting approximately three months post-birth. • RSV causes approximately 100,000 hospitalizations and 300-400 deaths annually among US infants, making this vaccine potentially transformative for preventing severe respiratory illness in the most vulnerable population.

Scientific advisory committee to examine impact of offering routine MenB jabs to wider range of peopleThe Kent meningitis outbreak: what is happening and why?Experts are considering expanding the meningitis B vaccination eligibility in response to the fatal outbreak of the disease in Kent.The Joint Committee on Vaccination and Immunisation’s review comes after the health secretary, Wes Streeting, asked it to to “re-examine eligibility for meningitis vaccines” for a wider range of people than those who currently qualify. Continue reading...

• Trump 2.0 policies terminated or overhauled HHS advisory committees, including ACIP with all members replaced in January 2026 by RFK Jr., leading to weakened hepatitis B and COVID-19 vaccine recommendations. • NIH advisory councils have not met, with the director's committee disbanded for over a year; USPSTF has not met since March 2025. • Senator Murray criticized leadership for prohibiting NIH grant processes; new ACIP includes controversial figures like an Alzheimer's patient from the withdrawn aducanumab trial.

• A federal judge on Monday blocked HHS from implementing vaccine policy changes made by RFK Jr.'s revamped CDC Advisory Committee on Immunization Practices (ACIP), reversing all recent decisions. • The ruling leaves unresolved the status of the RSV vaccine for infants, potentially making it no longer free for children who need it, as its inclusion was authorized by the current advisers. • Public health experts are scrambling to understand ramifications, with health groups concerned about unintended harms and weakened vaccination recommendations for hepatitis B and COVID-19.